BioXcel Therapeutics Inc (BTAI)
NASDAQ
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -60571.429 | -666.52 | -85.828 | -82.481 | -64.112 | -46.555 | -74.449 | -128.099 |
Return on Equity (%) | 1308.642 | 695.1 | -101.67 | -100.231 | -70.353 | -49.925 | -111.082 | -1766.941 |
Return on Invested Capital (%) | 1308.642 | 513.526 | -106.763 | -102.314 | -70.504 | -49.947 | -81.768 | -161.37 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | -42011.733 | -12010.072 |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | -44201.867 | -12974.855 |
Book Value Per Share | N/A | -0.099 | 2.483 | 1.487 | 8.465 | 7.922 | 2.728 | -1.93 |
Earnings Per Share | N/A | -0.458 | -1.23 | -1.823 | -3.365 | -3.822 | -5.889 | -6.117 |
Cash Per Share | N/A | 0.09 | 2.718 | 1.793 | 8.728 | 8.326 | 6.883 | 2.228 |
Working Capital Per Share | N/A | -0.146 | 2.459 | 1.418 | 8.405 | 7.868 | 6.039 | 1.533 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | 0.013 | 0.004 |
EBIT Per Share | N/A | -0.458 | -1.23 | -1.823 | -3.365 | -3.822 | -5.889 | -6.117 |
EBITDA Per Share | N/A | -0.458 | -1.23 | -1.823 | -3.365 | -3.822 | -5.889 | -6.117 |
Free Cash Flow Per Share | N/A | -0.458 | -1.21 | -1.783 | -3.36 | -3.816 | -5.896 | -6.127 |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | N/A | 9.91M | 15.66M | 18.09M | 24.42M | 27.98M | 28.15M | N/A |
Year End December 30 2023 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Shares Outstanding | 28.02M | 28.15M | N/A | 29.27M | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | -23994.66 | N/A | N/A | N/A | -3983.505 | N/A |
Net Profit Margin (%) | N/A | N/A | -25629.126 | N/A | N/A | N/A | -4603.265 | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 19.83M |
Price to Earnings Ratio | -0.11 |
Price to Sales Ratio | 13.93 |
Price to Cash Ratio | 0.29 |
Price to Book Ratio | -0.34 |
Dividend Yield | - |
Shares Outstanding | 42.75M |
Average Volume (1 week) | 747.14k |
Average Volume (1 Month) | 555.57k |
52 Week Change | -88.30% |
52 Week High | 4.17 |
52 Week Low | 0.4401 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.